ASX - By Stock
|
ATX |
Re:
Ann: First 26 Patients recruited in Phase 2A ACCENT Trial
|
|
optimistic punter
|
16 |
4.2K |
6 |
10/07/24 |
10/07/24 |
ASX - By Stock
|
16
|
4.2K
|
6
|
|
ASX - By Stock
|
ATX |
Re:
Ann: Presentation and Webinar
|
|
optimistic punter
|
12 |
4.7K |
10 |
12/06/24 |
12/06/24 |
ASX - By Stock
|
12
|
4.7K
|
10
|
|
ASX - By Stock
|
ATX |
Re:
Ann: Amplia Establishes World Class Clinical Advisory Board
|
|
optimistic punter
|
10 |
2.9K |
4 |
05/06/24 |
05/06/24 |
ASX - By Stock
|
10
|
2.9K
|
4
|
|
ASX - By Stock
|
ATX |
Re:
Ann: Preliminary Final Report and Annual Report YE 31 March 2024
|
|
optimistic punter
|
5 |
1.8K |
7 |
30/05/24 |
30/05/24 |
ASX - By Stock
|
5
|
1.8K
|
7
|
|
ASX - By Stock
|
ATX |
Re:
Ann: ASCO Conference Abstract
|
|
optimistic punter
|
4 |
1.7K |
2 |
27/05/24 |
27/05/24 |
ASX - By Stock
|
4
|
1.7K
|
2
|
|
ASX - By Stock
|
ATX |
Re:
Ann: Substantial Holder Notice - Blueflag Holding Pty Ltd
|
|
optimistic punter
|
4 |
1.3K |
2 |
15/05/24 |
15/05/24 |
ASX - By Stock
|
4
|
1.3K
|
2
|
|
ASX - By Stock
|
ATX |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
optimistic punter
|
5 |
1.8K |
3 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
5
|
1.8K
|
3
|
|
ASX - By Stock
|
ATX |
Re:
Ann: Trading Halt
|
|
optimistic punter
|
21 |
7.5K |
6 |
16/04/24 |
16/04/24 |
ASX - By Stock
|
21
|
7.5K
|
6
|
|
ASX - By Stock
|
ATX |
Re:
Ann: AACR Conference Presentation
|
|
optimistic punter
|
7 |
1.9K |
1 |
11/04/24 |
11/04/24 |
ASX - By Stock
|
7
|
1.9K
|
1
|
|
ASX - By Stock
|
ATX |
Re:
Ann: Update on ACCENT Trial in Pancreatic Cancer
|
|
optimistic punter
|
44 |
14K |
6 |
03/04/24 |
03/04/24 |
ASX - By Stock
|
44
|
14K
|
6
|
|
ASX - By Stock
|
ATX |
Re:
Ann: Update on ACCENT Trial in Pancreatic Cancer
|
|
optimistic punter
|
44 |
14K |
7 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
44
|
14K
|
7
|
|
ASX - By Stock
|
ATX |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
optimistic punter
|
58 |
16K |
4 |
21/03/24 |
21/03/24 |
ASX - By Stock
|
58
|
16K
|
4
|
|
ASX - By Stock
|
ATX |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
optimistic punter
|
58 |
16K |
1 |
13/03/24 |
13/03/24 |
ASX - By Stock
|
58
|
16K
|
1
|
|
ASX - By Stock
|
ATX |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
optimistic punter
|
58 |
16K |
1 |
29/02/24 |
29/02/24 |
ASX - By Stock
|
58
|
16K
|
1
|
|
ASX - By Stock
|
OZM |
Re:
OZM General Discussion
|
|
optimistic punter
|
1.6K |
286K |
0 |
28/02/24 |
28/02/24 |
ASX - By Stock
|
1.6K
|
286K
|
0
|
|
ASX - By Stock
|
ATX |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
optimistic punter
|
58 |
16K |
5 |
15/02/24 |
15/02/24 |
ASX - By Stock
|
58
|
16K
|
5
|
|
ASX - By Stock
|
OZM |
Re:
OZM General Discussion
|
|
optimistic punter
|
1.6K |
286K |
3 |
13/02/24 |
13/02/24 |
ASX - By Stock
|
1.6K
|
286K
|
3
|
|
ASX - By Stock
|
ATX |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
optimistic punter
|
58 |
16K |
3 |
01/02/24 |
01/02/24 |
ASX - By Stock
|
58
|
16K
|
3
|
|
ASX - By Stock
|
OZM |
Re:
OZM General Discussion
|
|
optimistic punter
|
1.6K |
286K |
2 |
29/01/24 |
29/01/24 |
ASX - By Stock
|
1.6K
|
286K
|
2
|
|
ASX - By Stock
|
ATX |
Re:
Ann: FDA Clearance Amplia's IND for Pancreatic Cancer Trial in US
|
|
optimistic punter
|
21 |
8.2K |
7 |
18/01/24 |
18/01/24 |
ASX - By Stock
|
21
|
8.2K
|
7
|
|
ASX - By Stock
|
ATX |
Re:
Ann: Pause in Trading
|
|
optimistic punter
|
11 |
2.9K |
4 |
17/01/24 |
17/01/24 |
ASX - By Stock
|
11
|
2.9K
|
4
|
|
ASX - By Stock
|
ATX |
Re:
Ann: Amplia Reports First Patient Dosing In Phase 2a Accent Trial
|
|
optimistic punter
|
2 |
1.0K |
6 |
17/01/24 |
17/01/24 |
ASX - By Stock
|
2
|
1.0K
|
6
|
|
ASX - By Stock
|
OZM |
Re:
OZM General Discussion
|
|
optimistic punter
|
1.6K |
286K |
4 |
11/01/24 |
11/01/24 |
ASX - By Stock
|
1.6K
|
286K
|
4
|
|
ASX - By Stock
|
ATX |
Re:
News: ATX Amplia Therapeutics Says Approval From Korean Regulator
|
|
optimistic punter
|
13 |
5.2K |
4 |
19/12/23 |
19/12/23 |
ASX - By Stock
|
13
|
5.2K
|
4
|
|
ASX - By Stock
|
OZM |
Re:
Ann: Presentation for RIU Resurgence Conference
|
|
optimistic punter
|
172 |
42K |
3 |
24/11/23 |
24/11/23 |
ASX - By Stock
|
172
|
42K
|
3
|
|
ASX - By Stock
|
OZM |
Re:
OZM General Discussion
|
|
optimistic punter
|
1.6K |
286K |
3 |
23/11/23 |
23/11/23 |
ASX - By Stock
|
1.6K
|
286K
|
3
|
|
ASX - By Stock
|
OZM |
Re:
OZM General Discussion
|
|
optimistic punter
|
1.6K |
286K |
4 |
23/11/23 |
23/11/23 |
ASX - By Stock
|
1.6K
|
286K
|
4
|
|
ASX - By Stock
|
OZM |
Re:
OZM General Discussion
|
|
optimistic punter
|
1.6K |
286K |
4 |
22/11/23 |
22/11/23 |
ASX - By Stock
|
1.6K
|
286K
|
4
|
|
ASX - By Stock
|
OZM |
Re:
OZM General Discussion
|
|
optimistic punter
|
1.6K |
286K |
7 |
22/11/23 |
22/11/23 |
ASX - By Stock
|
1.6K
|
286K
|
7
|
|
ASX - By Stock
|
ATX |
Re:
Ann: Promising Clinical Data 1b ACCENT Trial in Pancreatic Cancer
|
|
optimistic punter
|
26 |
9.0K |
2 |
22/11/23 |
22/11/23 |
ASX - By Stock
|
26
|
9.0K
|
2
|
|
ASX - By Stock
|
ATX |
Re:
Ann: Promising Clinical Data 1b ACCENT Trial in Pancreatic Cancer
|
|
optimistic punter
|
26 |
9.0K |
2 |
22/11/23 |
22/11/23 |
ASX - By Stock
|
26
|
9.0K
|
2
|
|
ASX - By Stock
|
ATX |
Re:
Ann: Promising Clinical Data 1b ACCENT Trial in Pancreatic Cancer
|
|
optimistic punter
|
26 |
9.0K |
4 |
17/11/23 |
17/11/23 |
ASX - By Stock
|
26
|
9.0K
|
4
|
|
ASX - By Stock
|
OZM |
Re:
OZM General Discussion
|
|
optimistic punter
|
1.6K |
286K |
13 |
16/11/23 |
16/11/23 |
ASX - By Stock
|
1.6K
|
286K
|
13
|
|
ASX - By Stock
|
OZM |
Re:
OZM General Discussion
|
|
optimistic punter
|
1.6K |
286K |
10 |
11/11/23 |
11/11/23 |
ASX - By Stock
|
1.6K
|
286K
|
10
|
|
ASX - By Stock
|
OZM |
Re:
Ann: Response to ASX Price Query
|
|
optimistic punter
|
78 |
17K |
4 |
08/11/23 |
08/11/23 |
ASX - By Stock
|
78
|
17K
|
4
|
|
ASX - By Stock
|
OZM |
Re:
Brazil Lithium Stocks
|
|
optimistic punter
|
39 |
8.2K |
7 |
08/11/23 |
08/11/23 |
ASX - By Stock
|
39
|
8.2K
|
7
|
|
ASX - By Stock
|
ATX |
Re:
Ann: Promising Clinical Data 1b ACCENT Trial in Pancreatic Cancer
|
|
optimistic punter
|
26 |
9.0K |
3 |
06/11/23 |
06/11/23 |
ASX - By Stock
|
26
|
9.0K
|
3
|
|
ASX - By Stock
|
OZM |
Re:
Ann: Quarterly Activities/Appendix 5B Cash Flow Report
|
|
optimistic punter
|
181 |
32K |
7 |
31/10/23 |
31/10/23 |
ASX - By Stock
|
181
|
32K
|
7
|
|
ASX - By Stock
|
ATX |
Re:
Ann: Promising Clinical Data 1b ACCENT Trial in Pancreatic Cancer
|
|
optimistic punter
|
26 |
9.0K |
3 |
30/10/23 |
30/10/23 |
ASX - By Stock
|
26
|
9.0K
|
3
|
|
ASX - By Stock
|
ATX |
Re:
Ann: Promising Clinical Data 1b ACCENT Trial in Pancreatic Cancer
|
|
optimistic punter
|
26 |
9.0K |
5 |
30/10/23 |
30/10/23 |
ASX - By Stock
|
26
|
9.0K
|
5
|
|
ASX - By Stock
|
ATX |
Re:
Ann: ACCENT Trial Recruitment Update
|
|
optimistic punter
|
21 |
7.4K |
0 |
29/10/23 |
29/10/23 |
ASX - By Stock
|
21
|
7.4K
|
0
|
|
ASX - By Stock
|
OZM |
Re:
Ann: OzAurum Acquires Lithium Project in Brazil
|
|
optimistic punter
|
373 |
82K |
6 |
20/10/23 |
20/10/23 |
ASX - By Stock
|
373
|
82K
|
6
|
|
ASX - By Stock
|
OZM |
Re:
Ann: OzAurum Acquires Lithium Project in Brazil
|
|
optimistic punter
|
373 |
82K |
8 |
20/10/23 |
20/10/23 |
ASX - By Stock
|
373
|
82K
|
8
|
|
ASX - By Stock
|
OZM |
Re:
Ann: OzAurum Acquires Lithium Project in Brazil
|
|
optimistic punter
|
373 |
82K |
9 |
17/10/23 |
17/10/23 |
ASX - By Stock
|
373
|
82K
|
9
|
|
ASX - By Stock
|
ATX |
Re:
Ann: ACCENT Trial Recruitment Update
|
|
optimistic punter
|
21 |
7.4K |
2 |
12/10/23 |
12/10/23 |
ASX - By Stock
|
21
|
7.4K
|
2
|
|
ASX - By Stock
|
OZM |
Re:
Ann: Amended Announcement - Brazil Lithium Due Diligence Complete
|
|
optimistic punter
|
250 |
52K |
18 |
08/10/23 |
08/10/23 |
ASX - By Stock
|
250
|
52K
|
18
|
|
ASX - By Stock
|
OZM |
Re:
Ann: Amended Announcement - Brazil Lithium Due Diligence Complete
|
|
optimistic punter
|
250 |
52K |
7 |
29/09/23 |
29/09/23 |
ASX - By Stock
|
250
|
52K
|
7
|
|
ASX - By Stock
|
OZM |
Re:
Ann: Amended Announcement - Brazil Lithium Due Diligence Complete
|
|
optimistic punter
|
250 |
52K |
6 |
28/09/23 |
28/09/23 |
ASX - By Stock
|
250
|
52K
|
6
|
|
ASX - By Stock
|
OZM |
Re:
Ann: Amended Announcement - Brazil Lithium Due Diligence Complete
|
|
optimistic punter
|
250 |
52K |
12 |
27/09/23 |
27/09/23 |
ASX - By Stock
|
250
|
52K
|
12
|
|
ASX - By Stock
|
OZM |
Re:
Ann: Investor Presentation
|
|
optimistic punter
|
194 |
48K |
9 |
27/09/23 |
27/09/23 |
ASX - By Stock
|
194
|
48K
|
9
|
|